Year in Review: Follicular Lymphoma
(MedPage Today) -- Credit: Patho
Studies demonstrating high response rates and manageable safety profiles, along with FDA approvals, have supported bispecific antibodies as promising treatment options for follicular lymphoma.
At the start...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news